Results 81 to 90 of about 95,511,506 (302)
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic +10 more
wiley +1 more source
Dagstuhl Reports, Volume 2, Issue 10, October 2012, Complete Issue
Dagstuhl Reports, Volume 2, Issue 10, October 2012, Complete ...
core +1 more source
Extracellular vesicle (EV) lipidomic profiling of plasma and ascites from patients with high‐grade serous ovarian cancer and of ovarian cancer cell lines reveals enrichment of triglycerides (TGs), diacylglycerols (DGs), phosphatidylcholine (PCs), sphingomyelins (SMs), reflecting tumor metabolic reprogramming.
Shikha Rani +9 more
wiley +1 more source
Dagstuhl Reports, Volume 4, Issue 10, October 2014, Complete Issue
Dagstuhl Reports, Volume 4, Issue 10, October 2014, Complete ...
core +1 more source
Isocitrate dehydrogenase 1 (IDH1) mutations are highly recurrent in multiple human cancer types, including cholangiocarcinoma and glioma. IDH1 R132C is the most common IDH1 mutation in cholangiocarcinoma and likely arises from APOBEC3A‐ or APOBEC3B‐mediated deamination.
Kelly E. Butler +3 more
wiley +1 more source
Dagstuhl Reports, Table of Contents, Volume 15, Issue 10, 2025
Dagstuhl Reports, Table of Contents, Volume 15, Issue 10 ...
core +1 more source
Dagstuhl Reports, Volume 3, Issue 10, October 2013, Complete Issue
Dagstuhl Reports, Volume 3, Issue 10, October 2013, Complete ...
core +1 more source
The kinase SRPK1 directly interacts with the protein TOPBP1 and regulates the pre‐mRNA splicing of WIZ thereby contributing to the activation of the ATR/CHK1 replicative checkpoint in response to replicative stress. This allows cancer cells' genomic stability and survival.
Amani Shreim +17 more
wiley +1 more source
Dagstuhl Reports, Volume 7, Issue 10, October 2017, Complete Issue
Dagstuhl Reports, Volume 7, Issue 10, October 2017, Complete ...
core +1 more source
Mutant p53R273H disrupts PDPK1 homodimerization and contributes to PDPK1 activation
How mutant p53R273H drives AKT signaling is unclear. We show that p53R273H, but not wild‐type, directly binds PDPK1 via a mutation‐dependent conformational change. This interaction disrupts inhibitory PDPK1 homodimerization and enhances AKT phosphorylation.
Mei Chee Lim +11 more
wiley +1 more source

